evodiamine has been researched along with Cancer of Prostate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, P; Fan, J; Liu, C; Wang, X; Xu, C; Zhang, X; Zhao, X | 1 |
| Huang, X; Liang, C; Yu, Y; Zhang, P | 1 |
| Ahn, KS; Alharbi, SA; Blough, BE; Chinnathambi, A; Hwang, ST; Namjoshi, OA; Narula, AS; Um, JY | 1 |
| Huang, WJ; Kan, SF; Lin, LC; Wang, PS | 1 |
| Chen, MJ; Hsu, JM; Kan, SF; Pu, HF; Wang, PS; Yu, CH | 1 |
5 other study(ies) available for evodiamine and Cancer of Prostate
| Article | Year |
|---|---|
Identification of evodiamine as a suppressor of prostate cancer progression by reducing AR transcriptional activity via targeting Src.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Male; Prostate; Prostatic Neoplasms; Quinazolines; Receptors, Androgen | 2022 |
Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer.
Topics: Adult; Animals; B7-H1 Antigen; Ferroptosis; Histones; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Nude; Prostatic Neoplasms; Semaphorin-3A; Vascular Endothelial Growth Factor A | 2023 |
Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; DNA Damage; Down-Regulation; Gene Expression Regulation, Neoplastic; Gene Silencing; Hepatocyte Growth Factor; Humans; Male; Models, Biological; Neoplasm Proteins; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-met; Quinazolines; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor | 2020 |
Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Caspases; CDC2 Protein Kinase; Cell Cycle; Cell Division; Cell Line, Tumor; Coloring Agents; Dose-Response Relationship, Drug; Flow Cytometry; G2 Phase; Histones; Humans; In Situ Nick-End Labeling; L-Lactate Dehydrogenase; Male; Mitosis; Models, Chemical; Plant Extracts; Ploidies; Prostatic Neoplasms; Quinazolines; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |
Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3.
Topics: Androgens; Apoptosis; Carcinoma; Caspase 3; Caspase 8; Caspase 9; CDC2 Protein Kinase; Cell Division; Cell Line, Tumor; Culture Media; Cyclin B; Cyclin B1; DNA Fragmentation; DNA, Neoplasm; Dose-Response Relationship, Drug; Flow Cytometry; G2 Phase; Humans; L-Lactate Dehydrogenase; Male; Plant Extracts; Prostatic Neoplasms; Purines; Quinazolines; Roscovitine | 2007 |